Axa S.A. X4 Pharmaceuticals, Inc Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Axa S.A. holds 3,076,941 shares of XFOR stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,076,941

Previous 3,076,077 0.03%

Holding current value

$1.08 Million

Previous $1.78 Million 15.53%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.54 - $0.86 $466 - $743	864 Added 0.03%	3,076,941 $2.06 Million
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.47 $988 - $2,506	1,705 Added 0.06%	3,076,077 $1.78 Million
Q1 2024 May 15, 2024	BUY	$0.72 - $1.46 $604 - $1,226	840 Added 0.03%	3,074,372 $4.27 Million
Q4 2023 Jul 16, 2024	SELL	$0.61 - $0.99 $512 - $831	-840 Reduced 0.03%	3,073,532 $2.58 Million
Q4 2023 Feb 14, 2024	SELL	$0.61 - $0.99 $45,343 - $73,589	-74,333 Reduced 2.36%	3,073,532 $2.58 Million
Q3 2023 Nov 14, 2023	SELL	$1.03 - $2.02 $285,436 - $559,788	-277,123 Reduced 8.09%	3,147,865 $3.43 Million
Q2 2023 Aug 14, 2023	SELL	$0.82 - $2.49 $796,613 - $2.42 Million	-971,480 Reduced 22.1%	3,424,988 $6.64 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $1.22 $27,861 - $42,488	34,827 Added 0.8%	4,396,468 $3.82 Million
Q4 2022 Feb 14, 2023	BUY	$0.69 - $2.21 $162,274 - $519,750	235,181 Added 5.7%	4,361,641 $4.32 Million
Q3 2022 Feb 14, 2023	BUY	$0.89 - $1.71 $2.65 Million - $5.09 Million	2,975,993 Added 258.68%	4,126,460 $3.8 Million
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $2.65 Million - $5.09 Million	2,975,993 Added 258.68%	4,126,460 $7.06 Million
Q2 2022 Feb 14, 2023	SELL	$0.88 - $1.91 $768 - $1,667	-873 Reduced 0.08%	1,150,467 $1.1 Million
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.91 $768 - $1,667	-873 Reduced 0.08%	1,150,467 $1.11 Million
Q1 2022 Feb 14, 2023	SELL	$1.48 - $2.58 $4.4 Million - $7.68 Million	-2,975,120 Reduced 72.1%	1,151,340 $2.01 Million
Q1 2022 May 13, 2022	SELL	$1.48 - $2.58 $708 - $1,235	-479 Reduced 0.04%	1,151,340 $2.02 Million
Q4 2021 Feb 14, 2022	BUY	$1.9 - $5.6 $1.07 Million - $3.14 Million	561,550 Added 95.13%	1,151,819 $2.64 Million
Q3 2021 Nov 15, 2021	BUY	$4.53 - $6.45 $98,994 - $140,951	21,853 Added 3.84%	590,269 $3.12 Million
Q2 2021 Aug 13, 2021	SELL	$6.49 - $9.56 $2,797 - $4,120	-431 Reduced 0.08%	568,416 $3.7 Million
Q1 2021 May 14, 2021	SELL	$6.63 - $10.28 $981 - $1,521	-148 Reduced 0.03%	568,847 $4.9 Million
Q4 2020 Feb 12, 2021	BUY	$5.41 - $7.4 $123,980 - $169,585	22,917 Added 4.2%	568,995 $3.66 Million
Q3 2020 Nov 13, 2020	BUY	$6.09 - $9.15 $149,472 - $224,577	24,544 Added 4.71%	546,078 $3.7 Million
Q2 2020 Aug 14, 2020	BUY	$7.98 - $10.44 $154,580 - $202,233	19,371 Added 3.86%	521,534 $4.86 Million
Q1 2020 May 15, 2020	BUY	$6.03 - $11.01 $3.03 Million - $5.53 Million	502,163 New	502,163 $5.02 Million

Others Institutions Holding XFOR

# of Institutions

104

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $24M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account